• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因表达数据训练的有监督机器学习的浸润性导管癌进展分类模型。

Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.

机构信息

International Centre for Genetic Engineering and Biotechnology, New Delhi, India.

出版信息

Sci Rep. 2020 Mar 5;10(1):4113. doi: 10.1038/s41598-020-60740-w.

DOI:10.1038/s41598-020-60740-w
PMID:32139710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7057992/
Abstract

Early detection of breast cancer and its correct stage determination are important for prognosis and rendering appropriate personalized clinical treatment to breast cancer patients. However, despite considerable efforts and progress, there is a need to identify the specific genomic factors responsible for, or accompanying Invasive Ductal Carcinoma (IDC) progression stages, which can aid the determination of the correct cancer stages. We have developed two-class machine-learning classification models to differentiate the early and late stages of IDC. The prediction models are trained with RNA-seq gene expression profiles representing different IDC stages of 610 patients, obtained from The Cancer Genome Atlas (TCGA). Different supervised learning algorithms were trained and evaluated with an enriched model learning, facilitated by different feature selection methods. We also developed a machine-learning classifier trained on the same datasets with training sets reduced data corresponding to IDC driver genes. Based on these two classifiers, we have developed a web-server Duct-BRCA-CSP to predict early stage from late stages of IDC based on input RNA-seq gene expression profiles. The analysis conducted by us also enables deeper insights into the stage-dependent molecular events accompanying IDC progression. The server is publicly available at http://bioinfo.icgeb.res.in/duct-BRCA-CSP.

摘要

早期发现乳腺癌及其正确分期对预后和为乳腺癌患者提供适当的个性化临床治疗至关重要。然而,尽管付出了相当大的努力和取得了进展,但仍需要确定导致浸润性导管癌 (IDC) 进展阶段的具体基因组因素,这有助于确定正确的癌症分期。我们开发了两种机器学习分类模型来区分 IDC 的早期和晚期。预测模型是使用来自癌症基因组图谱 (TCGA) 的代表 610 名患者不同 IDC 阶段的 RNA-seq 基因表达谱进行训练的。使用不同的特征选择方法,通过丰富的模型学习,对不同的监督学习算法进行了训练和评估。我们还使用来自 IDC 驱动基因的训练集减少数据的相同数据集上开发了一个机器学习分类器进行训练。基于这两个分类器,我们开发了一个基于输入 RNA-seq 基因表达谱的 web 服务器 Duct-BRCA-CSP,用于从 IDC 的晚期预测早期阶段。我们的分析还使我们能够更深入地了解伴随 IDC 进展的阶段依赖性分子事件。该服务器可在 http://bioinfo.icgeb.res.in/duct-BRCA-CSP 上公开获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/a7972aa220e3/41598_2020_60740_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/be3cd388d9d4/41598_2020_60740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/c719f29d8307/41598_2020_60740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/75b5c58a0a11/41598_2020_60740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/4f48bba80bb1/41598_2020_60740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/1c14bde15dc4/41598_2020_60740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/f9f49b38941a/41598_2020_60740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/9bde9a5c1302/41598_2020_60740_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/b746b02aa4a9/41598_2020_60740_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/a7972aa220e3/41598_2020_60740_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/be3cd388d9d4/41598_2020_60740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/c719f29d8307/41598_2020_60740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/75b5c58a0a11/41598_2020_60740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/4f48bba80bb1/41598_2020_60740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/1c14bde15dc4/41598_2020_60740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/f9f49b38941a/41598_2020_60740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/9bde9a5c1302/41598_2020_60740_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/b746b02aa4a9/41598_2020_60740_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c0/7057992/a7972aa220e3/41598_2020_60740_Fig9_HTML.jpg

相似文献

1
Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.基于基因表达数据训练的有监督机器学习的浸润性导管癌进展分类模型。
Sci Rep. 2020 Mar 5;10(1):4113. doi: 10.1038/s41598-020-60740-w.
2
Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.使用混合特征选择方法和深度学习架构增强从基因表达谱预测浸润性导管癌乳腺癌分期的能力。
Med Biol Eng Comput. 2023 Nov;61(11):2895-2919. doi: 10.1007/s11517-023-02892-1. Epub 2023 Aug 2.
3
Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.用于癌症诊断的空间转录组学特征的识别和转移。
Breast Cancer Res. 2020 Jan 13;22(1):6. doi: 10.1186/s13058-019-1242-9.
4
Relationship Between ADAMTS8, ADAMTS18, and ADAMTS20 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Expressions and Tumor Molecular Classification, Clinical Pathological Parameters, and Prognosis in Breast Invasive Ductal Carcinoma.ADAMTS8、ADAMTS18 和 ADAMTS20(含血栓反应蛋白基序的解整合素和金属蛋白酶)表达与乳腺浸润性导管癌的肿瘤分子分类、临床病理参数和预后的关系。
Med Sci Monit. 2018 Jun 3;24:3726-3735. doi: 10.12659/MSM.907310.
5
Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.两种主要致癌途径的基因组和转录组描绘:侵袭性导管乳腺癌发展的调控机制
Oncotarget. 2015 Nov 3;6(34):36652-74. doi: 10.18632/oncotarget.5543.
6
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.体内导管原位癌进展模型的表达谱分析确定B细胞淋巴瘤-9是乳腺癌侵袭的分子驱动因素。
Breast Cancer Res. 2015 Sep 17;17:128. doi: 10.1186/s13058-015-0630-z.
7
Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.系统生物学综合分析乳腺癌,以鉴定与基于 TNM 的临床分期相关的关键基因模块和基因。
Sci Rep. 2020 Jul 2;10(1):10816. doi: 10.1038/s41598-020-67643-w.
8
Machine learning models to predict the progression from early to late stages of papillary renal cell carcinoma.机器学习模型预测肾乳头状细胞癌早期到晚期的进展。
Comput Biol Med. 2018 Sep 1;100:92-99. doi: 10.1016/j.compbiomed.2018.06.030. Epub 2018 Jun 28.
9
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.伴导管原位癌成分的浸润性导管癌(IDC/DCIS)与单纯浸润性导管癌(IDC)的比较:临床病理特征、分子亚型和临床结局的比较。
J Cancer Res Clin Oncol. 2019 Jul;145(7):1877-1886. doi: 10.1007/s00432-019-02930-2. Epub 2019 May 14.
10
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.管腔型浸润性导管癌与管腔型浸润性小叶癌临床结局的比较。
BMC Cancer. 2016 Mar 25;16:248. doi: 10.1186/s12885-016-2275-4.

引用本文的文献

1
Gene expression and agent-based modeling improve precision prognosis in breast cancer.基因表达与基于主体的建模改善乳腺癌的精准预后。
Sci Rep. 2025 May 16;15(1):17059. doi: 10.1038/s41598-025-01275-w.
2
Protooncogenic Role of and in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers.原癌基因 和 在浸润性导管癌中的作用:两个有前途的乳腺癌生物标志物。
Biomed Res Int. 2023 Nov 23;2023:8236853. doi: 10.1155/2023/8236853. eCollection 2023.
3
Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.

本文引用的文献

1
Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications.鉴定与早期乳腺癌相关的 lncRNAs 及其预后意义。
Mol Oncol. 2019 Jun;13(6):1342-1355. doi: 10.1002/1878-0261.12489. Epub 2019 May 8.
2
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.NUP98-三阴性乳腺癌对蒽环类化疗反应的新预测因子。
BMC Cancer. 2019 Apr 2;19(1):236. doi: 10.1186/s12885-019-5407-9.
3
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer.
开发一种单分子计数分析方法以在临床上鉴别嫌色性肾细胞癌和嗜酸细胞瘤。
Cancers (Basel). 2022 Jul 1;14(13):3242. doi: 10.3390/cancers14133242.
4
Machine Learning Algorithm for Distinguishing Ductal Carcinoma In Situ from Invasive Breast Cancer.用于区分导管原位癌与浸润性乳腺癌的机器学习算法
Cancers (Basel). 2022 May 15;14(10):2437. doi: 10.3390/cancers14102437.
5
Increasing prediction accuracy of pathogenic staging by sample augmentation with a GAN.通过生成对抗网络(GAN)进行样本增强来提高致病分期的预测准确性。
PLoS One. 2021 Apr 27;16(4):e0250458. doi: 10.1371/journal.pone.0250458. eCollection 2021.
Y盒结合蛋白YBX1及其相关基因作为乳腺癌患者不良预后的生物标志物。
Oncotarget. 2018 Dec 14;9(98):37216-37228. doi: 10.18632/oncotarget.26469.
4
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.COSMIC 癌症基因目录:描述所有人类癌症中的遗传功能障碍。
Nat Rev Cancer. 2018 Nov;18(11):696-705. doi: 10.1038/s41568-018-0060-1.
5
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.野生型 p53 通过 GAS7-CYFIP1 介导的信号通路上调早期乳腺癌相关基因 GAS7 以抑制转移。
Oncogene. 2018 Jul;37(30):4137-4150. doi: 10.1038/s41388-018-0253-9. Epub 2018 Apr 30.
6
Comprehensive Characterization of Cancer Driver Genes and Mutations.全面描绘癌症驱动基因和突变。
Cell. 2018 Apr 5;173(2):371-385.e18. doi: 10.1016/j.cell.2018.02.060.
7
Identification of the potential crucial genes in invasive ductal carcinoma using bioinformatics analysis.使用生物信息学分析鉴定浸润性导管癌中的潜在关键基因。
Oncotarget. 2017 Dec 13;9(6):6800-6813. doi: 10.18632/oncotarget.23239. eCollection 2018 Jan 23.
8
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation.HLA介导的肿瘤逃逸机制可能通过T细胞激活损害免疫治疗的临床疗效。
Oncol Lett. 2017 Oct;14(4):4415-4427. doi: 10.3892/ol.2017.6784. Epub 2017 Aug 21.
9
Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer.乳腺癌中的基因表达谱分析及其对早期乳腺癌治疗选择的影响。
Eur J Breast Health. 2017 Oct 1;13(4):168-174. doi: 10.5152/ejbh.2017.3636. eCollection 2017 Oct.
10
Cystathionine- γ-lyase promotes process of breast cancer in association with STAT3 signaling pathway.胱硫醚-γ-裂解酶通过与信号转导和转录激活因子3(STAT3)信号通路相关联来促进乳腺癌进程。
Oncotarget. 2017 Aug 7;8(39):65677-65686. doi: 10.18632/oncotarget.20057. eCollection 2017 Sep 12.